Fundraising FoxOticara
1 known investors
Find your way into Oticara
Sign up to see every warm intro you have to Oticara
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oticara team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oticara is a clinical-stage biopharmaceutical company developing an investigational intranasal corticosteroid therapy for chronic rhinosinusitis (CRS). Its product is a single-dose, semisolid emulsion formulation placed by an ENT physician under endoscopic guidance, targeting patients with persistent symptoms after topical therapies and sinus surgery.
Investors · 1
Frequently asked questions
- What does Oticara do?
- Oticara is a clinical-stage biopharmaceutical company developing an investigational intranasal corticosteroid therapy for chronic rhinosinusitis (CRS). Its product is a single-dose, semisolid emulsion formulation placed by an ENT physician under endoscopic guidance, targeting patients with persistent symptoms after topical therapies and sinus surgery.
- Who are Oticara's investors?
- Oticara's investors include K20 Fund.